  Fetal neuroinflammation and prenatal stress (PS) may contribute to lifelong
neurological disabilities. Astrocytes and microglia, among the brain's
non-neuronal glia cell populations, play a pivotal role in neurodevelopment,
predisposition to and initiation of disease throughout lifespan. One of the
most common neurodevelopmental disorders manifesting between 1-4 years of age
is autism spectrum disorder (ASD). A pathological glial-neuronal interplay is
thought to increase the risk for clinical manifestation of ASD in at-risk
children, but the mechanisms remain poorly understood and integrative,
multi-scale models are needed. We propose a model that integrates the data
across the scales of physiological organization, from genome to phenotype, and
provides a foundation to explain the disparate findings on the genomic level.
We hypothesize that via gene-environment interactions, fetal neuroinflammation
and PS may reprogram glial immunometabolic phenotypes that impact
neurodevelopment and neurobehavior. Drawing on genomic data from the recently
published series of ovine and rodent glial transcriptome analyses with fetuses
exposed to neuroinflammation or PS, we conduct an analysis on the Simons
Foundation Autism Research Initiative (SFARI) Gene database. We confirm 21 gene
hits. Using unsupervised statistical network analysis, we then identify six
clusters of probable protein-protein interactions mapping onto the
immunometabolic and stress response networks and epigenetic memory. These
findings support our hypothesis. We discuss the implications for ASD etiology,
early detection, and novel therapeutic approaches. We conclude with delineation
of the next steps to verify our model on the individual gene level in an
assumption-free manner.
